The process in question is a medical evaluation used by employers or their insurance carriers in the context of workplace injury claims. It involves analyzing a biological specimen to detect the presence of prohibited substances. For instance, following an accident at a construction site, an injured worker may be required to submit a urine sample for such an analysis to determine if substance use contributed to the incident.
This evaluation serves several key functions, including ensuring workplace safety, mitigating financial risk for employers, and potentially reducing insurance premiums. Historically, its implementation has been driven by a desire to create safer work environments and to manage the rising costs associated with workplace accidents and associated liabilities. This practice is often mandated by company policy and may be subject to state and federal regulations.
